Here are three points:
1. The shares were sold at $57.92 per share for a total value of $836,773.
2. The 52-week high of NuVasive is $60.09 and the 52-week low is $36.81.
3. The company has a market cap of $2.8 billion.
More articles on devices:
Stryker leads $84M hip & knee orthopedic surgical robot device markets: 5 key points
Disc replacement driving spine industry — KICVentures comments on industry shift: 7 insights
In light of acquisition, Zimmer Biomet joins LDR in push for Mobi-C reimbursement: 5 things to know
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
